e-learning
resources
Stockholm 2002
Sunday 15.09.2002
Prevalence and costs of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence and severity of GOLD defined COPD in adults
A. Johannessen, P. S. Bakke, E. Omenaas, A. Gulsvik (Bergen, Norway)
Source:
Annual Congress 2002 - Prevalence and costs of COPD
Session:
Prevalence and costs of COPD
Session type:
Thematic Poster Session
Number:
820
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Johannessen, P. S. Bakke, E. Omenaas, A. Gulsvik (Bergen, Norway). Prevalence and severity of GOLD defined COPD in adults. Eur Respir J 2002; 20: Suppl. 38, 820
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Distribution of COPD patients in the GOLD assessment framework by exacerbations
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
The prevalence of QTc-prolongation increase by GOLD stage in COPD
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017
Agreement of severity stages and exacerbations building the new COPD risk groups
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014
Prevalence of comorbidities in patients with COPD in south-Spain
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Global cardiovascular disease risk in U.S. adults by severity and presence of COPD
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Prevalence of chronic symptoms and bronchial obstruction according to the GOLD classification in the young adult general population
Source: Eur Respir J 2003; 22: Suppl. 45, 214s
Year: 2003
Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment framework
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Disease severity in COPD patients
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003
The frequency of COPD exacerbations is related to the comorbidity profile
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Stability of the exacerbation pattern defined by GOLD 2017 in a real-world COPD population
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Socioeconomic status shaping GOLD A-D classification in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept